World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
45776
World Ranking
17788
National Ranking
49

Overview

Jose C. Nicolau is affiliated with the Universidade de São Paulo in Brazil. Their research is primarily situated within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, where they have contributed to 129 publications. Additional subfields of study include Surgery, Endocrinology, Diabetes and Metabolism, Infectious Diseases, and Radiology, Nuclear Medicine and Imaging.

The scientist's work covers several key topics relevant to cardiovascular and metabolic health, including:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Cardiac Imaging and Diagnostics

Jose C. Nicolau has an extensive publication record in notable journals and venues. Some of the frequent publication venues are:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • Arquivos Brasileiros de Cardiologia
  • Zenodo (CERN European Organization for Nuclear Research)

Among the recent papers coauthored or associated with Nicolau are:

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) published in The Lancet
  • Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021), Bristol Research (University of Bristol)
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes (2020) in JAMA
  • Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022), European Heart Journal
  • Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists (2021), JACC Heart Failure

Jose C. Nicolau has collaborated frequently with several researchers, including:

  • Talia Falcão Dalçóquio
  • Rocío Salsoso
  • Felipe Gallego Lima
  • Remo Holanda de Mendonça Furtado
  • Luciano Baracioli

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

    Marc P. Bonaca;Deepak L. Bhatt;Marc Cohen;Philippe Gabriel Steg

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Vorapaxar in the secondary prevention of atherothrombotic events

    David A. Morrow;Eugene Braunwald;Marc P. Bonaca;Sebastian F. Ameriso

  • Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

    Robert O. Bonow;Gerald Maurer;Kerry L. Lee;Thomas A. Holly

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    A. Michael Lincoff;Stephen J. Nicholls;Jeffrey S. Riesmeyer;Philip J. Barter

  • IV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia

    Andrei C. Sposito;Bruno Caramelli;Francisco A. H. Fonseca;Marcelo C. Bertolami

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients

    Paul M. Ridker;James Revkin;Pierre Amarenco;Robert Brunell

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

    Piotr Ponikowski;Bridget-Anne Kirwan;Bridget-Anne Kirwan;Stefan D Anker;Theresa McDonagh;Theresa McDonagh

  • Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure

    Bertram Pitt;Harvey White;Jose Nicolau;Felipe Martinez

  • Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.

    Stefan James;Dominick J. Angiolillo;Jan H. Cornel;David Erlinge

  • Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

    Claes Held;Nils Åsenblad;Jean Pierre Bassand;Richard C. Becker

  • Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.

    Christopher B. Granger;Kenneth W. Mahaffey;W. Douglas Weaver;Pierre Theroux

  • International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina

    E Topol;R Califf;F Van De Werf;R Diaz

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

Frequent Co-Authors

Shaun G. Goodman
Shaun G. Goodman University of Toronto
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Christopher B. Granger
Christopher B. Granger Duke University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Robert F. Storey
Robert F. Storey University of Sheffield
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
Eugene Braunwald
Eugene Braunwald Harvard Medical School
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Harvey D. White
Harvey D. White Auckland City Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if a traditional medical degree is right for you? There are a variety of flexible, online options to explore.

Consider a pharmacy degree online if you are drawn to medication management, patient care, and pharmaceutical research. Pharmacy programs can open doors to rewarding roles beyond hospitals, including research, retail, or industry settings.

If you like working with data and technology, healthcare informatics degree programs train students to manage and analyze health information, a crucial skill for modern healthcare systems.

For those seeking quick entry into the healthcare field, you might wonder how much is medical billing and coding school. Training can often be completed in under a year, leading to roles in hospitals, clinics, or insurance companies.

Nurses wanting to advance should look into the cheapest fnp programs online. These programs prepare you for high-demand nurse practitioner positions while letting you study flexibly.

Each of these online pathways offers a unique route into healthcare careers, accommodating different interests, budgets, and schedules.

Best Scientists Citing Jose C. Nicolau

Trending Scientists

Recently Published Articles